Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Hancock Jaffe Laboratories (HJLI) stocks in Canada

Learn how to easily invest in Hancock Jaffe Laboratories stocks.

Hancock Jaffe Laboratories is a medical devices business based in the US. Hancock Jaffe Laboratories stocks (HJLI.US) are listed on the NASDAQ and all prices are listed in US Dollars. Hancock Jaffe Laboratories employs 19 staff and has a market cap (total outstanding stock value) of $98.3 million.

How to buy shares in Hancock Jaffe Laboratories

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – HJLI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Hancock Jaffe Laboratories stock price (NASDAQ:HJLI)

Use our graph to track the performance of HJLI stocks over time.

Hancock Jaffe Laboratories shares at a glance

Information last updated 2022-01-16.
52-week range$4.99 - $11.38
50-day moving average $9.02
200-day moving average $6.95
Wall St. target price$26.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.71

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Hancock Jaffe Laboratories stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Hancock Jaffe Laboratories price performance over time

Historical closes compared with the close of $N/A from 2021-12-08

1 week (2022-01-13) N/A
1 month (2021-12-20) N/A
3 months (2021-10-22) -100.00%
6 months (2021-07-23) -100.00%
1 year (2021-01-22) -100.00%
2 years (2020-01-24) -100.00%
3 years (2019-01-24) -100.00%
5 years (2017-01-20) N/A

Hancock Jaffe Laboratories financials

Gross profit TTM $-4,252,249
Return on assets TTM -30.58%
Return on equity TTM -55.76%
Profit margin 0%
Book value $4.80
Market capitalisation $98.3 million

TTM: trailing 12 months

Hancock Jaffe Laboratories share dividends

We're not expecting Hancock Jaffe Laboratories to pay a dividend over the next 12 months.

Have Hancock Jaffe Laboratories's shares ever split?

Hancock Jaffe Laboratories's shares were split on a 1:25 basis on 29 November 2020. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Hancock Jaffe Laboratories shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Hancock Jaffe Laboratories shares which in turn could have impacted Hancock Jaffe Laboratories's share price.

Hancock Jaffe Laboratories share price volatility

Over the last 12 months, Hancock Jaffe Laboratories's shares have ranged in value from as little as $4.99 up to $11.38. A popular way to gauge a stock's volatility is its "beta".

HJLI.US volatility(beta: 1.54)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Hancock Jaffe Laboratories's is 1.5404. This would suggest that Hancock Jaffe Laboratories's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Hancock Jaffe Laboratories overview

Hancock Jaffe Laboratories, Inc. , a medical device company, develops and sells tissue-based solutions for patients with cardiovascular disease, and peripheral arterial and venous disease in the United States and Europe. It engages in the development and manufacture of bioprosthetic medical devices for cardiovascular diseases, including the VenoValve, a porcine based device to be surgically implanted in the deep venous system of the leg to treat reflux associated with chronic venous insufficiency; and the CoreoGraft, a bovine based off the shelf conduit to be used to revascularize the heart during coronary artery bypass graft surgeries. The company was founded in 1987 and is headquartered in Irvine, California. Hancock Jaffe Laboratories, Inc. is a subsidiary of Leman Cardiovascular SA. .

Hancock Jaffe Laboratories in the news

There are no recent company news

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site